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bstract
A sensitive and selective liquid chromatography–tandem mass spectrometry method was developed and validated for the simultaneous quantitative
etermination of microcystin-LR (MC-LR) and its glutathione conjugate (MC-LR-GSH) in fish tissues. The analytes were extracted from fish
iver and kidney using 0.01 M EDTA–Na2–5% acetic acid, followed by a solid-phase extraction (SPE) on Oasis HLB and silica cartridges. High-
erformance liquid chromatography (HPLC) with electrospray ionization mass spectrometry, operating in selected reaction monitoring (SRM)
ode, was used to quantify MC-LR and its glutathione conjugate in fish liver and kidney. Recoveries of analytes were assessed at three concentrations
0.2, 1.0, and 5g g−1 dry weight [DW]) and ranged from 91 to 103% for MC-LR, and from 65.0 to 75.7% for MC-LR-GSH. The assay was
−1 −1inear within the range from 0.02 to 5.0g g DW, with a limit of quantification (LOQ) of 0.02g g DW. The limit of detection (LOD) of the
ethod was 0.007g g−1 DW in both fish liver and kidney. The overall precision was determined on three different days. The values for within-
nd between-day precision in liver and kidney were within 15%. This method was applied to the identification and quantification of MC-LR and
ts glutathione conjugate in liver and kidney of fish with acute exposure of MC-LR.
 2007 Elsevier B.V. All rights reserved.
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. Introduction
Microcystins (MCs) are potent monocyclic heptapeptides
roduced by many members of cyanobacteria, including
icrocystis, Anabaena, and Planktothrix [1,2]. They have
common moiety composed of five amino acids: 3-
mino-9-methoxy-l0- phenyl-2,6,8-trimethyldeca-4,6-dienoic
cid (Adda), N-methyldehydroalanine (Mdha), d-alanine, -
inked d-erythro--methylaspartic acid and -linked d-glutamic
cid, and two l-amino acids as variants [3]. Microcystins are
amed according to their variable l-amino acids, for example,
C-LR contains leucine (L) and arginine (R) [4]. Over 70 MCsave been successively isolated and identified [5], among which
C-LR is one of the most commonly occurring species [6]. To
ate, most of the works on microcystins have been conducted
∗ Corresponding author. Tel.: +86 27 68780622; fax: +86 27 68780622.
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sing the two variants l-amino acids as because of its presence
n most countries reporting toxic episodes [7].
MC-LR has a relative molecular mass of about 995. Among
he microcystins reported, MC-LR is one of the most toxic, with
median lethal dose (LD50) of 50g kg−1 body weight (BW)
1]. In recent studies, it has been found MC-LR is a potent
nhibitor of protein phosphatases 1 and 2A and has a tumor-
romoting activity in the rat liver [8,9]. Microcystins, especially
C-LR, cause adverse effects on mammals, birds, and fish and
ave been recognized as a potent stress factor and health hazard
actor in aquatic ecosystems with heavy blooms occurring [10],
nd also represent a threat to human health through drinking
ater and the food chains [11]. In order to withstand increasing
hemical stressors, many organisms have developed a complex
etoxication metabolism, consisting of three phases: (1) acti-
ation (P450-monooxygenases); (2) conjugation (glutathione
-transferases, and other transferases); and (3) further process-
ng, deposition, or excretion [12]. Microcystins are metabolized
rimarily by glutathione S-transferases (GSTs) [13]. The major
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ST-derived metabolites of MCs are the glutathione conjugates.
his conjugation appears to be the first step of detoxication
f MCs in aquatic organisms [14]. Thus, to better understand
he mechanism of detoxification of MCs in aquatic organisms,
he simultaneous determination of MCs and their glutathione
onjugate is of great importance and urgency.
Due to the low concentrations of the MC-LR and its
lutathione conjugate, and much disturbance species in fish
issues, it is needed to establish a selective and sensitive
nalytical technology for their identification and/or quan-
ification in metabolic organs, such as liver and kidney.
here have been many analytical methods for MC-LR,
ncluding protein phosphatase inhibition assay (PPIA) [15],
nzyme-linked immunosorbent assay (ELISA) [16], liq-
id chromatography (LC) [17–19], capillary electrophoresis
CE) [20,21] and liquid chromatography–mass spectrome-
ry (LC–MS) [22–24]. Because of its high specificity and
ensitivity, liquid chromatography–tandem mass spectrometry
LC/MS/MS) has become the method of choice for quantita-
ive determination of analytes in biological samples [25–27].
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Fig. 1. Chemical structures of microcystin-. B  862 (2008) 43–50
or MC-LR-GSH, the previous studies primarily focused on
he qualitative analyses and no quantitative analyses have been
eveloped [14,28,29]. Kondo et al. [28] described the qualita-
ive detection of the metabolites of microcystin-RR and -LR
ormed in vivo in mouse and rat liver by both HPLC and
rit-FAB LC/MS. Pflugmacher et al. [14] identified an enzy-
atically formed glutathione conjugate of the cyanobacterial
epatotoxin MC-LR by HPLC and MALDI–TOF-MS. Ito et al.
29] applied an immunostaining method to the study of absorp-
ion and distribution of MC-LR and its glutathione conjugate
n different tissues in mice. So far, there have been no lit-
ratures to report simultaneous quantitative determination of
C-LR and its glutathione conjugate in fish or other animal
issues.
This paper detailed, for the first time, an analytical method
or the simultaneous quantitative determination of MC-LR and
ts glutathione conjugate in fish liver and kidney using SPE,
nd LCQ Advantage MAX ion trap LC/MS with ESI(+) and
RM. The extraction procedure was optimized in order to obtain
ufficiently high recoveries for MC-LR and its glutathione con-
LR and microcystin-LR-glutathione.
matogr. B  862 (2008) 43–50 45
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Table 1
MS/MS parameters for MC-LR and MC-LR-GSH
MC-LR MC-LR-GSH
Nominal molecular mass (Da) 994.5 1301.8
Isolation width (m/z) 2.0 2.0
Normalized collision energy (%) 36 24
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ugate, and the LC and MS/MS conditions were also investigated
n order to detect these compounds at a very low concentra-
ion.
. Experimental
.1. Chemicals
MC-LR (Fig. 1) was isolated and purified from surface
looms collected from Lake Dianchi in China using an improved
amanan method [30]. In this method, the extraction of micro-
ystis cells was sequentially applied to an octadecylsilyl (ODS)
artridge and semi-prep-LC (Waters 600, USA). The content of
urified MC-LR was over 95% and its identity was confirmed
y LC–MS. MC-LR-GSH (Fig. 1) was prepared by modifica-
ion of the method of Kondo et al. [31]. Briefly, MC-LR reacted
ith GSH in 5% potassium carbonate aqueous solution while
tirring for 2 h at room temperature. The reaction mixture was
eutralized with 0.2 M hydrochloric acid and applied to an ODS
artridge. The cartridge was rinsed with water and elute by
ethanol to give the reaction product. The reaction product was
urified further by semi-prep-LC (Waters 600, USA). The con-
ent of purified glutathione conjugate of MC-LR was over 95%
nd confirmed by HPLC and LC–MS. The chemical characteri-
ation of MC-LR-GSH was performed by using multiple stages
f MSn. Glutathione (GSH) was purchased from Acros Organics
Geel, Belgium) and its purity was greater than 99%. Methanol
as of HPLC grade (TEDIA company, INC., Fairfield, OH,
SA). Water was purified in a WaterProTM PS system (Lab-
onco Company, Kansas City, MO, USA). Other reagents were
ll analytical reagent grade.
.2. Instrumentation
A Surveyor HPLC system (Thermo Electron Corporation,
an Jose, CA, USA) including a Surveyor LC pump, a Surveyor
utosampler and a Surveyor photoelectric diode array (PDA)
etector combined with a LCQ Advantage MAX mass spec-
rograph (Thermo Electron Corporation, San Jose, CA, USA)
quipped with electrospray ionization probe was used for all
nalyses.
An Agilent StableBond C18 column (2.1 mm i.d. × 150 mm
ength, 3.5m, Agilent Corporation, Santa Clara, CA, USA)
as applied. Solution A of the elution system was formic
cid–water solution (0.05%, v/v) while solution B was formic
cid–methanol solution (0.05%, v/v). At analysis stage the ana-
ytes were eluted with the following gradient program: 0 min
95% A, 5% B), 0.5 min (65% A, 35% B), 14 min (25% A,
5% B), 21 min (25% A, 75% B). The total flow rate was held
t 0.2 mL min−1 at analysis stage. After the analysis stage, the
ercentage of solution B was adjusted to 5% and the flow rate
as increased to 0.3 mL min−1 for 4 min before the next injec-
ion to renew the initial condition rapidly. The injection volume
as 10L. The temperatures of vial tray and column oven
n the autosampler were set to 10 ◦C and 25 ◦C, respectively.
he effluent was transferred on-line to ESI–MS system without
plitting.
C
J
t
2recursor ions (m/z) 995.5 652.2
roduct ions (m/z) 599.2; 977.4 587.3; 1168.4
Infusion into the ion trap tandem mass spectrometer was per-
ormed as follows: the flow of standard compounds (5g mL−1)
oming from an integrated syringe pump at a flow rate of
L min−1 for tuning the mass spectrometer and optimizing
he ESI source. The ESI source and MS/MS parameters were
utomatically optimized and saved in a tune file. Spray needle
oltage was set at 4.5 kV for MC-LR and MC-LR-GSH, auto-
atic gain control (AGC) was on, maximum isolation time was
00 ms, and three microscans per scan were acquired. Voltages
n capillary and tube lens were 45.5 and 55 V for MC-LR, and
0.2 and 50 V for MC-LR-GSH, respectively. These were set
y automatic optimization using the LCQ autotune program on
he mass spectrometer. Nitrogen was used as a sheath and aux-
liary gas. Helium was used as a collision gas in the ion trap.
he sheath gas flow rate was set at 20 units (a scale of arbitrary
nits in the 0–100 range defined in the LCQ system), the aux-
liary gas was turned off, and capillary temperature was 250 ◦C
or MC-LR and MC-LR-GSH. MS/MS parameters for MC-LR
nd MC-LR-GSH, including their precursor and product ions,
ollision energy and isolation width were summarized in Table 1.
.3. Materials
Crucian carp (Carassius auratus), weighing 265 ± 22.6 g
ere obtained from a fish hatchery affiliated to College of Fish-
ries, Huazhong Agricultural University in Wuhan City, China.
he liver and kidney were obtained from several untreated
ealthy fish, immediately frozen and freeze-dried for analytical
ethod development. Before being used as matrices, the tissue
amples were analyzed using the developed method in this study
nd no MC-LR and MC-LR-GSH were detected.
.4. Sample preparation
The lyophilized liver and kidney samples (50 mg) were
piked with three concentration levels of MC-LR and MC-
R-GSH. The low, medium, and high levels consisted of
.01, 0.05, 0.25g of MC-LR and MC-LR-GSH, respectively.
liquots of the spiked lyophilized samples were homogenized
n a mortar and added to centrifuge tubes. Fifty milligram
amples were extracted three times with 5 mL water with
DTA–Na2 (0.01 M)–5% acetic acid for sonicating 3 min (30%
ptitude, 60 W, 20 KHz, Branson Digital Sonifier, Danbury,
T, USA) at 0 ◦C and then centrifuged at 12,000 × g (BR4,
ouan,Winchester, VA, France) at room temperature with three
imes repeated. Stock solutions were prepared by dissolving
mg of MC-LR and 2 mg MC-LR-GSH in pure water. Work-
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ng standard solutions were prepared by serial dilutions of stock
olutions using pure water. Quality control (QC) samples were
repared from the SPE extract of lyophilized liver and kidney
amples (50 mg) spiked with low, medium and high concentra-
ions (0.2, 1.0, and 5g g−1 dry weight [DW]). All solutions
ere stored at −20 ◦C before use.
.5. Cleanup procedure
The samples were purified according to the method of Xie et
l. [32] with the replacement of the solid-phase extraction (SPE)
orbent from C18 to Oasis HLB cartridges. The newly optimized
urification procedure was described as follows. The spiked liver
r kidney sample (50 mg) was first applied to an Oasis HLB car-
ridge (500 mg/6 mL, Waters, Milford, MA, USA), which had
een preconditioned by 100% methanol and distilled water. The
olumn containing sample was washed with 20% MeOH 20 mL
nd then eluted with 100% MeOH 20 mL. The eluant collected
rom the HLB cartridges was evaporated to dryness. The residue
as dissolved in 100% MeOH 2 mL and the solution was applied
o a Sep-Pak silica gel (2 g/12 mL, Waters, Milford, MA, USA)
artridge which had been preconditioned by 100% MeOH. The
ilica gel column containing the analyte was washed with 20 mL
f 100% MeOH and then eluted with 20 mL of 70% MeOH. This
lution fraction was also evaporated to dryness and the residue
as dissolved in 100% MeOH. Finally, the extract was evap-
rated to dryness and redissolved in 100L of the LC mobile
hase and transferred to HPLC autosampler vials. The aliquots
10L) were injected into the LC–MS system.
.6. Method validation
Calibration samples in liver and kidney were prepared
y mixing a series of solutions at varying concentrations
f MC-LR and MC-LR-GSH with fish blank liver and kid-
ey sample extracts cleaned up by SPE to form a series of
oncentrations with 0.02, 0.10, 0.2, 1.0, 2.0, and 5.0g g−1
C-LR and MC-LR-GSH. Precision of the assay was deter-
ined by performing replicated analyses of QC samples
gainst calibration standards. The precision of the method
as calculated as the relative standard deviation (RSD) of
bserved concentration. The extraction recovery expressed as
ean ± standard deviation (SD) was determined by calculating
he ratio of the amount of extracted compound from drug-free
iver and kidney spiked with known amounts of MC-LR and
C-LR-GSH to the amount of compound added at the same
oncentrations in the mobile phase solution. The stability of
amples was also investigated by measuring lyophilized liver
nd kidney samples spiked with low and high concentrations
nd QC samples. Freeze–thaw stability, short-term temperature
nd post-preparative stability were determined according to
nalysis of biological samples guidelines by the FDA (available
rom URL:http://www.fda.gov/cder/guidance/4252fnl.htm).
he limit of detection (LOD) was considered as three times
he signal/noise ratio (S/N) and the LOQ was 10 times the
/N ratio. The selectivity of the method was characterized by
ssessing accurate quantification of MC-LR and MC-LR-GSH
f
k. B  862 (2008) 43–50
n the presence of endogenous compound, which was confirmed
y the analysis of blank and QC samples.
.7. Pharmacokinetic studies
The LC/MS/MS method was applied to pharmacokinetic
tudies of MC-LR and its glutathione conjugate in crucian carp
C. auratus). Crucian carp allowed to acclimate for 14 days,
rior to experiment, and were fasted for 48 h before the initiation
f the experiment. After healthy crucian carp were intraperi-
oneally injected with 100g MC-LR kg−1 BW, the liver and
idney were collected at 0, 1, 3, 12, 24, and 48 h postinjection,
espectively. Tissue samples were sealed and stored at −20 ◦C
ntil the analysis. Tissue samples were extracted and cleaned up
ollowing the methods described above. MC-LR and MC-LR-
SH concentrations in liver and kidney were determined by the
C–MS and three replicated analyses were performed.
. Result and discussion
.1. Characterization of MC-LR and its glutathione
onjugate
MC-LR and its glutathione conjugate were first analyzed
y LC–MS using the ion trap. For MC-LR, precursor ion was
M + H]+ at m/z 995.5. Collision energy was 42%. Product ions
m/z) included 599.3, 553.2, 866.4, 967.4, and 977.4, which are
dentical with that of the standard sample (MC-LR, Wako Pure
hemical Industries, Japan). For MC-LR-GSH, the precursor
on was at m/z of 1302.8, which was consistent with the [M + H]+
or MC-LR-GSH formed via addition of GSH to MC-LR and a
wo electron oxidation. The doubly protonated ion ([M + 2H]2+,
/z 652.0) was also observed (Fig. 2A). The [M + H]+ at m/z
302.8 was then used as precursor ion for a product-ion MS–MS
can. For subsequent MSn experiments, MS3 was carried out on
/z 1173.5 and MS4 was carried out on m/z 995.5. And collision
nergy for MS2, MS3 and MS4 were 30%, 34%, 42%, respec-
ively. The resulting product ion mass spectra for MC-LR-GSH
re shown in Fig. 2. Fig. 2B demonstrated the abundant product
on at m/z 1173.5, which was formed from the ion at 1302.8
y loss of a neutral fragmentation 129 Da. Fig. 2C gave two
rominent fragmentation ions at m/z 1155 and 995. The ion at
/z 1155 was formed from 1173 by loss of H2O. The ion at
/z 995 was formed from 1173 by loss of 178 Da (Gly–Cys). It
an also be assigned as [M + H − GSH]+. Fig. 2D showed prod-
ct ions at m/z 599.3, 553.2, 866.4, 967.4 and 977.4, which are
dentical with the product ions of MC-LR. These data obtained
rom dissociating the ion sequentially using MSn were also con-
istent with the structure of MC-LR-GSH described in Fig. 1.
he characteristic fragment ions in the (+)-ESI–MSn spectra of
C-LR-GSH are shown in Table 2.
.2. Method developmentIn the sample preparation, we compared the effect of dif-
erent extraction solvents on recovery of analytes in liver and
idney (Fig. 3). The extraction solvents evaluated were acidi-
M. Dai et al. / J. Chromatogr. B  862 (2008) 43–50 47
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ed methanol (0.05% TFA, v/v), EDTA–Na2 (0.01 M)–acidified
ethanol (0.05% TFA, v/v), 5% acetic acid and EDTA–Na2
0.01 M)–5% acetic acid. Experiments performed in triplicate
howed that EDTA–Na2 (0.01 M)–5% acetic acid yielded the
est recovery (over 90% for MC-LR and nearly 70% for MC-
R-GSH) (Fig. 3.). The unsatisfied results for acidified methanol0.05% TFA, v/v) and EDTA–Na2 (0.01 M)–acidified methanol
0.05% TFA, v/v) were speculated to be the presence of much
ore endogenous compounds which resulted in the obvious
on suppression in the assay processing. Our results also indi-
able 2
haracteristic fragment ions in the (+)-ESI–MSn spectra of MC-LR-GSH
ragment ions m/z
M + H]+ 1302.8
M + 2H]2+ 652.0
M − Glu + H]+ 1173.5
M − H2O + H]+ 1284.5
M − H2O − Glycine + H]+ 1209.5
Ala–Leu–MeAsp–Arg–Adda–Glu–Mdha–SH + H]+ 1029.5
M − Glu + Gly + H]+ 1116.5
M − Glu + H2O + H]+ 1155.5
M − Glu + CO + H]+ 1145.5
Ala–Leu–MeAsp–Arg–Adda–Glu–Mdha + H]+ 995.5
Arg–Adda–Glu + H]+ 599.3
Ala–Leu–MeAsp–Arg–Adda–Glu–Mdha − H2O + H]+ 977.5
Ala–Leu–MeAsp–Arg–Adda–Glu–Mdha − CO + H]+ 967.4
Mdha–Ala–Leu–MeAsp–Arg–Adda + H]+ 866.4
Mdha–Ala–Leu–MeAsp–Arg + H]+ 553.3
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a) MS scan, (B) MS2 scan, (C) MS3 scan, (D) MS4 scan.
ated that MC-LR-GSH might interact more intensively with
rotein and/or metal ions than MC-LR because of the added
COOH and NH2 (Fig. 1), which resulted in lower recoveries.
herefore, the EDTA–Na2 (0.01 M)–5% acetic acid system was
hosen and tested as an efficient solvent.
After the sample preparation, a cleanup method utilizing a
ombination of HLB and silica gel cartridge was chosen to
btain clean extract of MC-LR and MC-LR-GSH. The HLB sor-
ent was a copolymer designed to have a hydrophilic–lipophilic
alance that gave higher and more reproducible recoveries for
C-LR and MC-LR-GSH than C18 sorbent.
In this process, the suppression of ionization was evalu-
ted by comparing the absolute peak areas of the extracts of
iver and kidney spiked with a known amount of analytes to
eat standard injected directly in the same reconstituted solvent.
esults indicated that combination of HLB and silica gel car-
ridge improved the sample clean-up and thereby decreased the
mount of matrix injected onto the column and the ion suppres-
ion effect was minimized to less than 12%. While the HLB
artridge was used separately, the ion suppression effect was
ore than 50%.
An Agilent StableBond C18 column was applied for the
hromatographic separation and a C18 guard column was
sed to protect the analytical column. Other chromatographic
onditions, especially the composition of mobile phase, were
ptimized through several trails to obtain good resolution, sym-
etric peak shapes and a short run time. It was found that use of
mixture of methanol and water with 0.05% formic acid could
48 M. Dai et al. / J. Chromatogr
Fig. 3. Recoveries of MC-LR and MC-LR-GSH spiked in liver (A) and kidney
(B) by different extraction solvent systems: a, acidified methanol (0.05% TFA,
v/v); b, EDTA–Na2 (0.01 M)–acidified methanol (0.05% TFA, v/v); c, 5% acetic
acid; d, EDTA–Na2 (0.01 M)–5% acetic acid.
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Fig. 4. Selected reaction monitoring (SRM) chromatogram and product ion mass
concentrations of MC-LR and MC-LR-GSH were 0.5g mL−1.. B  862 (2008) 43–50
chieve these goals and was finally adopted as the mobile phase
or the chromatographic separation.
For the quantification of MC-LR and MC-LR-GSH in fish
iver and kidney, some parameters related to mass spectro-
etric detection were investigated. The capillary temperature,
aporizer temperature, and flow rate were optimized to obtain
rotonated molecules of the analytes. The fragment energy
as optimized to achieve maximum response of the fragment
on peaks. Selected reaction monitoring (SRM) using tandem
ass spectrometer (MS/MS) refers to the dedicated use of a
ass spectrometer to acquire and record ion current at only
elected mass-to-charge ratio (m/z) values, resulting in higher
nalytical sensitivity and selectivity in complex matrices. Con-
idering the interference from many ion of the same m/z ratio
n the tissue samples and higher signal-noise ratio, SRM mode
as chosen in the MS/MS experiments. The protonated pre-
ursor molecular ions [M + H]+ of MC-LR (m/z 995.5) and
he protonated precursor molecular ions [M + 2H]2+ of MC-
R-GSH (m/z 652.0) were selected and fragmented by helium
as collision in the ion trap at a relative collision energy of
4%. For MC-LR, the most abundant product ions were at m/z
99.2 ([Arg–Adda–Glu + H]+) and 977.4 ([M + H–H2O]+) and
or MC-LR-GSH at m/z 587.3 ([M + 2H–MeAsp]2+) and 1168.4
[M + H–Adda]+). These product ions were extracted for quan-
ification (Fig. 4).
.3. SelectivityLC–MS analysis of extracts of fish liver and kidney indi-
ated little interference from fish tissue matrix compounds as
o interfering peaks were present at the known retention time
nd mass-to-charge ratios of MC-LR and MC-LR-GSH. The
spectrum of the studied MC-LR-GSH (A, C) and MC-LR (B, D). Spiking
M. Dai et al. / J. Chromatog
Table 3
Calibration equations for the determination of MC-LR and MC-LR-GSH by
liquid chromatography ion-trap tandem mass spectrometry (X, concentration
g mL−1; Y, peak area)
Compound Sample Regression equations r2
MC-LR Liver Y = −47031.8 + 1.84172e + 006 × X 0.9943
Kidney Y = −35664.4 + 1.91313e + 006 × X 0.9968
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KC-LR-GSH Liver Y = 22553.4 + 1.76444e + 006 × X 0.9940
Kidney Y = −3152.94 + 1.70044e + 006 × X 0.9953
etention times were 19.6 min for MC-LR and 18.1 min for MC-
R-GSH. The product ions for quantitative determination of
nalyte were at m/z 599.2, 977.4 for MC-LR and m/z 587.3,
168.4 for MC-LR-GSH.
.4. Linearity
To evaluate the linearity of the LC/MS/MS method, the cali-
ration curves were created for MC-LR and MC-LR-GSH both
n liver and kidney matrices (Table 3). The correlation coeffi-
ient (r2) values for the calibration curves were both >99%. The
ssay was proved to be linear and acceptable. Good linearity was
bserved over the concentration ranges of 0.02–5.0g g−1 DW
or liver and kidney.
.5. Precision and detection limitsThe precision of the method was assessed in both liver and
idney by performing replicated analyses of spiked samples
gainst calibration standards. The procedure was repeated on
he same day and for different days on the same spiked standard
k
r
r
c
able 4
recisions of the method expressed as RSD for the different analytes in liver and kidn
nalyte Inter-assay RSD (%, n = 5)
Lowa Mediumb High
C-LR (liver) 11.2 7.5 2.5
C-LR-GSH (liver) 2.3 8.8 8.8
C-LR (kidney) 4.5 6.9 2.1
C-LR-GSH (kidney) 5.6 4.7 3.0
a Low fortification: 0.2g g−1 for MC-LR and MC-LR-GSH.
b Medium fortification: 1.0g g−1 for MC-LR and MC-LR-GSH.
c High fortification: 5.0g g−1 for MC-LR and MC-LR-GSH.
able 5
ecoveries of MC-LR and MC-LR-GSH in fish liver and kidney (mean ± SD, n = 3)
reatment Spiked (g g−1) MC-LR
Mean ± SD (%)
iver 0. 2 94.5 ± 13.5
1.0 91.0 ± 4.3
5.0 95.8 ± 18.1
idney 0.2 97.5 ± 14.3
1.0 97.8 ± 9.7
5.0 103.6 ± 11.8r. B  862 (2008) 43–50 49
eries. The within-day and between-day precisions of the method
re presented in Table 4. The data indicate that the precision
f the method are acceptable. LOD and LOQ were calculated
sing QC samples with low concentration of MC-LR and MC-
R-GSH. The LOD and LOQ values were 0.02g g−1DW and
.007g g−1DW, respectively, in both fish liver and kidney.
.6. Recovery
The recovery of an analyte in an assay is the detector response
btained from an amount of the analyte added to and extracted
rom the biological matrices compared to the detector response
btained for the true concentration of the pure authentic stan-
ard. The recovery was determined for fish liver and kidney
piked with low, medium, and high concentrations of MC-LR
nd MC-LR-GSH with three replicates, respectively. The results
re summarized in Table 5. The average recovery of MC-LR in
iver and kidney spiked with low, medium, and high concentra-
ions were all >90% and of MC-LR-GSH >70% except the liver
ample spiked with low concentration, which indicated that the
ecovery of MC-LR and MC-LR-GSH from fish liver and kid-
ey was concentration-independent in the concentration range
valuated.
.7. Stability
The freeze and thaw stability of the analytes was tested. Three
liquots at each of the low and high concentrations in liver and
idney were kept at −20 ◦C for 24 h and thawed unassisted at
oom temperature. After a complete thaw, the samples were
efrozen for 24 h under the same conditions. The freeze–thaw
ycle was repeated three times before analysis. The results
ey
Intra-assay RSD (%, 3 days)
c Low Medium High
11.4 12.8 4.8
12.9 8.6 8.3
7.1 4.9 2.9
11.1 6.4 5.3
MC-LR-GSH
RSD (%) Mean ± SD (%) RSD (%)
14.2 65.0 ± 5.2 8.1
4.82 72.7 ± 2.2 3.1
18.8 75.3 ± 2.03 2.7
14.6 75.6 ± 14.2 18.7
9.9 74.2 ± 2.5 3.3
11.3 72.8 ± 5.4 7.5
50 M. Dai et al. / J. Chromatogr
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[ig. 5. The mean (n = 3) liver concentration–time profiles for MC-LR and
C-LR-GSH after the intraperitoneal injection of single dose of MC-LR
100g kg−1 BW) to crucian carps.
howed that MC-LR and MC-LR-GSH were stable after three
reeze–thaw cycles in 72 h. The short-term temperature stability
xperiments showed that MC-LR and MC-LR-GSH at low and
igh concentrations in liver and kidney samples were stable at
oom temperature for at least 24 h. The post-preparative stabil-
ty of QC samples kept in the autosampler which was set 4 ◦C
or 24 h was also assessed. The mean recoveries of the low and
igh QC level in liver and kidney were more than 90%, which
uggested that MC-LR and MC-LR-GSH could remain at 4 ◦C
or at least 24 h. Therefore, MC-LR and MC-LR-GSH could be
onsidered to be stable in both liver and kidney matrices under
rozen storage and assay processing.
.8. Application
The method was applied to analyze the liver and kidney
amples obtained from crucian carp after the intraperitoneal
njection of single dose of MC-LR. The mean (n = 3) liver
oncentration–time profiles for MC-LR and MC-LR-GSH were
hown in Fig. 5. In the liver, the maximum concentration of MC-
R was 0.59g g−1 DW at 1 h and the maximum concentration
f MC-LR-GSH was 0.083g g−1 DW at 24 h. In the kidney,
o MC-LR and MC-LR-GSH was detected.
. Conclusion
For the first time, the LC/MS/MS method was developed
nd validated for the simultaneous determination of MC-LR
nd its glutathione conjugate in fish tissues. It was shown to
e selective, sensitive, and reproducible. Acceptable recoveries
f analytes were obtained at three concentrations (low, medium,
nd high), which were in the range of 91–103% for MC-LR and
5.0–75.7% for MC-LR-GSH. Validation results demonstrated
hat this method can be applied for determining low concen-
rations of MC-LR and its glutathione conjugate in complex
iological matrices such as fish liver and kidney in pharmacoki-
etic studies. Following a slight modification, this method can
e also used to determine MC-LR and its glutathione conjugate
n various tissues of other aquatic organisms. It is currently being
sed to further pharmacokinetic studies.
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